Amgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug

Investing.com Gold reports: Amgen sales rise 4% in first quarter, submits label update to FDA on autoimmune drug. Full body text was unavailable at ingest time, so this brief is based on headline context.